FDA approves Lannett's new antidepressant

The Food and Drug Administration approved Lannett's paroxetine extended release tablets.

Paroxetine tablets are intended to treat patients with depression, obsessive-compulsive disorder, anxiety disorders and post-traumatic stress disorder.

The tablets are a generic version of Paxil CR tablets created by Weston, Fla.-based Apotex Technologies.

The company has already begun shipping the medicine to customers.

More articles on supply chain:

Roche's new HPV test earns FDA approval
6 latest FDA approvals
UPMC, IBM team up for better hospital supply chains

 

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like